NantHealth, Inc. (15)

Browse by Contract Category

Business Finance (9)
Uncategorized (6)

Contracts

Description of Securities (Filed With SEC on February 25, 2022)
Third Amended and Restated Promissory Note, dated April 27, 2021, by and between NantHealth, Inc. and Nant Capital LLC (Filed With SEC on April 28, 2021)
Open Market Sale Agreement (Filed With SEC on November 12, 2021)
Indenture, dated April 27, 2021, among NantHealth, Inc., NaviNet, Inc. and U.S. Bank National Association (Filed With SEC on April 28, 2021)
Second Amended and Restated Promissory Note, dated April 27, 2021, by and between NantHealth, Inc. and Nant Capital LLC (Filed With SEC on April 28, 2021)
Resale Registration Rights Agreement, dated April 27, 2021, by and among NantHealth, Inc. and certain buyers (Filed With SEC on April 28, 2021)
Form of Exchange Agreement by and between the Company and (Filed With SEC on April 14, 2021)
Form of Exchange Agreement by and between the Company and certain holders, dated as of April 1 (Filed With SEC on April 14, 2021)
Description of Securities (Filed With SEC on February 26, 2021)
Amended and Restated Promissory Note by and between the Company and Nant Capital, LLC dated as of December 31, 2020 (Filed With SEC on January 5, 2021)
Amendment No. 3 to Second Amended and Restated NantOmics Exclusive Reseller Agreement dated as of December 31, 2020 (Filed With SEC on January 5, 2021)
Open NMS Assignment Agreement, dated as of July 22, 2020, between the Registrant and Cambridge Equities, LP (Filed With SEC on August 10, 2020)
Description of Securities (Filed With SEC on February 28, 2020)
Asset Purchase Agreement dated as of January 13, 2020, among Masimo Corporation and VCCB Holdings, Inc., and NantHealth, Inc (Filed With SEC on February 28, 2020)
Amendment no. 2 to Second Amended and Restated Nantomics Exclusive Reseller Agreement (Filed With SEC on May 9, 2019)